A Trial to Characterize Differences in Blood Levels of Different Lots of Centanafadine QD XR and to Understand the Effect of Food on Blood Levels

Clinical trial NCT07253441 · COMPLETED

Trial details

NCT number: NCT07253441
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Attention Deficit Disorder With Hyperactivity

Start date: 2024-08-29
Primary completion: 2024-12-30
Enrollment: 174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.